SCHEMBL7010761

SCHEMBL7010761

N#Cc1ncncc1-c1ccc(CBr)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 9/20 0.34
CYP3A4 P08684 9/20 0.34
CYP2C19 P33261 8/20 0.34
CYP2D6 P10635 6/20 0.34
TSHR P16473 2/20 0.34
CYP11B2 P19099 2/20 0.33
CYP11B1 P15538 1/20 0.33
GRM2 Q14416 1/20 0.33
HSD17B10 Q99714 4/20 0.33
ALDH1A1 P00352 3/20 0.33
MAPK1 P28482 3/20 0.33
ALOX15 P16050 2/20 0.33
CLK4 Q9HAZ1 2/20 0.33
DGAT1 O75907 1/20 0.33
KDM4E B2RXH2 2/20 0.32
TDP1 Q9NUW8 3/20 0.32
HPGD P15428 2/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
THRB P10828 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7006695 0.79 ERBB2 (0.47) CYP1A2CYP3A4CYP2C19CYP2D6CYP11B2
SCHEMBL14555850 0.79 ERBB2 (0.47) CYP1A2CYP3A4CYP2C19CYP2D6ALDH1A1
SCHEMBL7683701 0.76 PRMT5 (0.43) CYP1A2CYP3A4CYP2C19CYP2D6TSHR
SCHEMBL7014026 0.75 PDK1 (0.43) CYP1A2CYP3A4ALDH1A1TDP1HPGD
SCHEMBL7685860 0.74 TNF (0.42) CYP2C19TSHRCYP11B2CYP11B1KDM4E
SCHEMBL7686051 0.70 CYP2A6 (0.42) CYP1A2CYP3A4CYP2C19CYP2D6TNF
SCHEMBL2559783 0.68 ATM (0.50) TSHRCYP11B2CYP11B1GRM2ALDH1A1
SCHEMBL29818856 0.68 L3MBTL1 (0.54) CYP11B2CYP11B1ALDH1A1MAPK1KDM4E
SCHEMBL26908157 0.68 L3MBTL1 (0.54) CYP11B2CYP11B1ALDH1A1MAPK1KDM4E
SCHEMBL3837608 0.67 AKT1 (0.58) CYP1A2CYP3A4CYP2C19CYP2D6TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1327631-A2 Fused heterocyclic compounds, their production and use as angiotensin II antagonists Takeda Chemical Industries, Ltd. (JP) 2003-07-16 EP disclosed
EP-0518033-B1 Fused heterocyclic compounds, their production and use TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2003-07-02 EP disclosed
US-5389641-A Fused heterocyclic compounds, having angiotensin II antagonistic activity TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1995-02-14 US disclosed
EP-0518033-A1 Fused heterocyclic compounds, their production and use TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1992-12-16 EP disclosed